BOSTON–(BUSINESS WIRE)–Battery Ventures, a global technology-focused investment firm, announced a significant majority investment in Titian Software Ltd., a UK-based company that develops innovative sample management software and related services for science laboratories of life. Specific terms were not disclosed.
London-based Titian manufactures technology for the entire sample management process, helping customers maximize the efficiency of their research and development. Specifically, the company’s Mosaic product improves the supply of samples, including compounds, biologics and reagents, essential to vital laboratory research and development processes. The company sells to industries such as pharmaceuticals and biopharmaceuticals; agroscience; contract research organizations; and nonprofit and academic groups.
Titien will use the new funds to support organic growth as well as potential future acquisitions, Battery general partner Jesse Feldman said.
“The broader life science sample management market is poised to grow further, with trends such as personalized medicine and genomic sequencing driving higher throughput screening in the lab, as well as the creation of new laboratories to support this activity. All of this will spur Titian’s growth,” Feldman said. Battery has extensive experience in the market, including previous investments in another sample management/preparation company and a lab software company.
Titian’s founder, Edmund Wilson, retains a significant stake in the business and will remain closely involved in running the business going forward.
“Titian has been on a solid growth trajectory lately,” Wilson said. “But our new partnership with Battery represents a key inflection point for the business that should allow us to grow even further, in part by leveraging Battery’s industry expertise, network and market knowledge. With the help of Battery, Titian can better capitalize on the exciting growth opportunities we see in the sample management industry. »
Titian’s Mosaic helps researchers better manage and automate critical processes, enabling its customers to maximize research efficiency and accelerate new drug discovery and delivery.
“Titian’s products are especially critical for many organizations right now, as increased lab automation can help organizations address labor shortages in today’s market,” said Battery’s Justin Rosner, who will join Titian’s board with Jesse Feldman. “More generally, lab automation helps Titian’s customers perform critical testing activities faster, more accurately and more efficiently.”
*For a full list of all of Battery’s investments and exits, click here.
Titien Software was founded in 1999 and specializes in sample management. It offers software products and consulting services that help customers improve the supply of samples (compounds, biologics and reagents) to their vital research processes. By using the company’s Mosaic software, Titian customers are seeing significant benefits in throughput, response time, error rate, labor costs, and sample retention performance of their sample banks. We use our experience integrating laboratory robotics into our systems to ensure that our customers get the most out of their investment in automation.
About Battery Ventures
Battery partners with exceptional founders and management teams to grow category-defining businesses in markets such as software and services, enterprise infrastructure, online markets, healthcare IT and industrial technology. Founded in 1983, the firm supports businesses at all stages, from seed and start-up to growth and buyout, and invests globally from six strategic locations: Boston; San Francisco and Menlo Park, California; Tel Aviv; London; and New York. Follow the company on Twitter @BatteryVentures, visit our website at www.battery.com and find a full list of Battery portfolio companies here.